Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity

Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity

US Patent 12059457 · Granted Aug 13, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody-drug conjugates through specific linker oligopeptides2024
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Sialylated fetuin-A as a marker of immunotherapy efficacy2021
Method of preparation of alpha galactosyl ceramides compounds2020
Method for treating IFNalpha related conditions2018
Vaccine composition for use against influenza2015
Methods of enhancing adjuvaticity of vaccine compositions2014
Increase of immune response and targeting by antigens and/or drug linkage2014
Compositions for and methods of enhancing the immune response to antigens2012
Compositions for and methods of enhancing the immune response to antigens2012